Announcements Trials
Browse Landscape

Status

Completed 12Recruiting 3Active not recruiting 3Unknown 2Terminated 2Suspended 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 5Other solid neoplasm 5Genitourinary 3Head & Neck 2Endocrine 2Tumor-Agnostic 1Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Genital Neoplasms, Female 1Endometrial Neoplasms 1

Interventions

Paclitaxel 24Carboplatin 18Bevacizumab 14Cisplatin 12pembrolizumab 7fluzoparib 7Drug Therapy 7Radiotherapy 6camrelizumab 5apatinib 5Topotecan 5Magnetic Resonance Spectroscopy 5Injections 5liposomal doxorubicin 4lenvatinib 4famitinib 4Tirzepatide 4Specimen Handling 4Platinum 4Observation 4Gemcitabine 4Brachytherapy 4toripalimab 3olaparib 3dostarlimab 3anlotinib 3Watchful Waiting 3Therapeutics 3Surveys and Questionnaires 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Interviews as Topic × Gynecologic × Clear all
NCT07015593 2025-06-11

Patient Journey in Advanced Gynecologic Cancers

Tongji Hospital

Not yet recruiting
780 enrolled
Gynecologic

Uterine Cervical Neoplasms, Genital Neoplasms, Female, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡